EPHA7 and colorectal cancer: In subgroup analysis, the survival advantage of EPHA7-MUT vs EPHA7-WT was prominent and consistent across sex, age, drug class, cancer type (except for colorectal cancer), TMB level, and CNA level (Fig. 3d, all Pinteraction > 0.05).